Enhancing Clinical Translation of Cancer Using Nanoinformatics.

Simple Summary: Two fields of artificial intelligence and nanomedicine are very effective tools in moving towards the goal of personalized medicine. Combination of these fields, i.e., nanoinformatics, enables better access to patient data as well as better nanomaterials design. An ongoing challenge...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 13; no. 10; pp. 2481 - 2482
Autores principales: Soltani, Madjid, Moradi Kashkooli, Farshad, Souri, Mohammad, Zare Harofte, Samaneh, Harati, Tina, Khadem, Atefeh, Haeri Pour, Mohammad, Raahemifar, Kaamran, Stadlbauer, Andreas, Meyer-Baese, Anke, Zimmermann, Max
Formato: equations & formulas pictorial review tables/charts Journal Article
Publicado: MDPI 5/15/2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150526170&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 150526170
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: 5/15/2021
      vid: 13
      iid: 10
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        150526170
        150526170
        150526170
        10.3390/cancers13102481
        150526170
      ppf: 2481
      ppct: 1
      formats:
      tig:
        atl: Enhancing Clinical Translation of Cancer Using Nanoinformatics.
      aug:
        au:
          Soltani, Madjid
          Moradi Kashkooli, Farshad
          Souri, Mohammad
          Zare Harofte, Samaneh
          Harati, Tina
          Khadem, Atefeh
          Haeri Pour, Mohammad
          Raahemifar, Kaamran
          Stadlbauer, Andreas
          Meyer-Baese, Anke
          Zimmermann, Max
        affil: Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran 19967-15433, Iran
      sug:
        subj:
          Neoplasms Drug Therapy
          Artificial Intelligence
          Nanomedicine
          Quality Improvement
          Nanostructures
          Drug Synergism
          Drug Delivery Systems
          Individualized Medicine
      ab: Simple Summary: Two fields of artificial intelligence and nanomedicine are very effective tools in moving towards the goal of personalized medicine. Combination of these fields, i.e., nanoinformatics, enables better access to patient data as well as better nanomaterials design. An ongoing challenge in all forms of drug administration for cancer patients is that drug synergy at any point in treatment is time-dependent, dose-dependent, and patient-specific. Moreover, high heterogeneities of intra-tumor and interpatient make it hard to rationally design diagnostic and dug delivery systems, as well as analyze their results. Integration of artificial intelligence methods (especially data mining, neural networks, and machine learning) can fill these gaps by using classification algorithms and pattern analysis to improve the accuracy of diagnosis, drug delivery, and treatment. In this study, the basic concepts in artificial intelligence are explained and the contributions of nanoinformatics in cancer treatment are reviewed. Application of drugs in high doses has been required due to the limitations of no specificity, short circulation half-lives, as well as low bioavailability and solubility. Higher toxicity is the result of high dosage administration of drug molecules that increase the side effects of the drugs. Recently, nanomedicine, that is the utilization of nanotechnology in healthcare with clinical applications, has made many advancements in the areas of cancer diagnosis and therapy. To overcome the challenge of patient-specificity as well as time- and dose-dependency of drug administration, artificial intelligence (AI) can be significantly beneficial for optimization of nanomedicine and combinatorial nanotherapy. AI has become a tool for researchers to manage complicated and big data, ranging from achieving complementary results to routine statistical analyses. AI enhances the prediction precision of treatment impact in cancer patients and specify estimation outcomes. Application of AI in nanotechnology leads to a new field of study, i.e., nanoinformatics. Besides, AI can be coupled with nanorobots, as an emerging technology, to develop targeted drug delivery systems. Furthermore, by the advancements in the nanomedicine field, AI-based combination therapy can facilitate the understanding of diagnosis and therapy of the cancer patients. The main objectives of this review are to discuss the current developments, possibilities, and future visions in naoinformatics, for providing more effective treatment for cancer patients.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        pictorial
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N